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for those drugs subsequently listed. RESULTS: Of more
than 400 submissions considered, 216 were initial sub-
missions for drug/indication pairs and 150/216 [69%]
were subsequently recommended for addition to the for-
mulary. Of those recommended for listing, 36/150 [24%]
applications presented claims of efficacy data that were
wholly dependent on surrogate endpoint data, and 68/
150 [45%] submissions relied on a combination of surro-
gate with intermediate and/or clinical endpoint data. Sev-
enty-four (49%) submissions presented some clinical end-
point data, but only 30/150 (20%) submissions were
based on clinical endpoint data alone. In calendar 1999
more than AUD 420 million was spent on drugs whose
efficacy had only been demonstrated against surrogate
endpoints, approximately one sixth of annual expendi-
ture. DISCUSSION: Decision-makers must at times con-
sider the adoption of therapies for which only surrogate
outcome data are available. Uncertainties inherent in esti-
mates of comparative efficacy and cost-effectiveness are
magnified when data are drawn from clinical trials that
report only surrogate outcome data. Comparative cost-
effectiveness analysis cannot give rise to technical or al-
locative efficiencies if the criteria on which assessments
are based are unreliable.
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Member satisfaction with health care delivered in man-
aged care organizations (MCOs) can have profound ef-
fects on the health outcomes for patients. In the U.S.,
health employer data information sets (HEDIS) guide-
lines list satisfaction with pharmacy services as an indica-
tor of quality of care. Pharmacy services are an important
component of health care benefits, and are frequently
listed as a patient dissatisfier. Dissatisfaction with phar-
maceutical care can lead to noncompliance, nonpersis-
tence, and delay necessary therapies. Increasingly, report
card type measurements are included as a segment of
MCO National Committee for Quality Assurance (NCQA)
accreditation evaluations. OBJECTIVES: The study pur-
pose was to assess satisfaction with pharmacy services in
two populations of a large MCO as a NCQA quality im-
provement/preventive health activity project. METHODS:
Patients using pharmaceutical services in varying practice
sites were surveyed via a mailed questionnaire to deter-
mine satisfaction with MCO pharmacy services. Statistical
analyses included use of analysis of variance (ANOVA)
with Tukey HSD follow-up tests, and chi-square compar-
isons. RESULTS: A 68% percent response rate was reached
with both surveys. In two U.S. metropolitan areas, satis-
faction with pharmacy services exceeded 80% in a sam-
ple of 2,500 patients with no gender or age differences in
levels of satisfaction. However, satisfaction with specific
types of pharmacies (independent community, food mar-
ket, chain community) was significantly different (P 
0.01) as analyzed via ANOVA for specific and general
components of pharmaceutical care delivery. Tukey HSD
follow up tests indicated a significantly lower level of sat-
isfaction in chain community pharmacies when com-
pared with the two other pharmacy types. A Pearson’s
correlation noted a directly positive relationship between
self-assessed health status and satisfaction with pharmacy
services (r  0.154, P  0.001). CONCLUSIONS: Satis-
faction with pharmacy services can be high in general in
MCOs, but it is important to further study levels of satis-
faction based on pharmacy type and patient health status.
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OBJECTIVES: To examine trends and ethnic differences
in ‘amenable’ mortality and to estimate the relative im-
pact of health care interventions in terms of gains in mor-
tality outcomes. METHODS: The method is based on the
premise that death from certain conditions should not
happen given appropriate and timely health care inter-
ventions. Age-standardized mortality rates per 100,000-
population were calculated for 16 ‘amenable’ causes of
death for six 5-year periods from 1965 to 1994, and for
each of the three major ethnic groups (Chinese, Malays
and Indians) for three 3-year periods from 1989 to 1997.
The rates were divided into those, which can be reduced
by timely therapeutic care for ‘treatable’ conditions (such
as asthma and appendicitis), or by primary preventive
measures for ‘preventable’ conditions (such as lung can-
cer and motor vehicle injury). RESULTS: Amenable mor-
tality was 43.2% of all-causes deaths. The rate was
higher in males (109.7) than in females (60.7). Amenable
mortality showed annual declines of 1.98% in males and
1.94% in females, while those in ‘non-amenable’ mortal-
ity were 1.08% and 1.37% respectively. The decline in
amenable mortality was contributed much more by the
decline in mortality from ‘treatable’ causes, than that from
‘preventable causes.’ By evaluating the decline in amenable
mortality relative to that in non-amenable mortality, it
would appear that there was a greater impact of health
care in males (27.0%) than in females (16.6%) between
1965 and 1994. Amenable mortality was lowest for Chinese,
and highest for Malays. Over the recent 9-year period
(1989–97), amenable mortality declined more in Chinese,
than in Malays and Indians. However, when concomi-
tant decline in non-amenable mortality was taken into
account, Malays have made the most gains from health
care interventions. CONCLUSION: In line with the find-
ings from European countries, amenable mortality in Sin-
gapore declined more than non-amenable mortality.
There were more significant gains in mortality outcomes
